Ying Zhang

1PUBLICATIONS
0CO-AUTHORS
Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 01, 2026
Analysis of quality-adjusted survival time without symptoms or toxicity for pembrolizumab plus chemotherapy as treatment for previously untreated participants with advanced or metastatic esophageal cancer.

Ying Zhang, Marc Diez Garcia, Sukrut Shah

Pageof 1

Frequent Collaborators